UAB Study Recognized At International AIDS Conference

Birmingham, AL – A University of Alabama at Birmingham study for a new HIV drug was recognized at last week's International AIDS Conference in Thailand. UAB participated in the trials that brought the drug Fuzeon to market earlier this year. Doctor Michael Kilby is medical director of UAB's 1917 Clinic. That's a nonprofit health and research clinic focused solely on HIV and AIDS. Kilby says researchers are excited about the drug that's the only one of its kind available through prescription. Fuzeon works on patients whose bodies have become resistant to traditional HIV treatments. The Centers for Disease Control and Prevention says more than 40 million people worldwide are infected with HIV...more than 93-hundred in Alabama alone.